Anti-BCMA CAR T-Cell Cytotoxicity Does Not Correlate with BCMA Expression on Primary Multiple Myeloma Cells but can be Enhanced by Treatment with GSIs. This evidence concerns the gene TNFRSF17 and AL amyloidosis.